Session: Consequences of non-adherence - Acare HCP Global
Skip to content
Home > Congress > Session > Session: Consequences of non-adherence to narrow therapeutic index drugs

Consequences of non-adherence to narrow therapeutic index drugs

This video is a recording of a session from a:care congress 2022.

Depending on its intensity and the context of its occurrence, a single seizure can have profound social and medical consequences for patients and can strongly affect their quality of life. In the case of NTIs, one single dose omission can result in a seizure and lead to preventable adverse events. Detailing the costs associated with non-adherence to anti-seizure medication and the limited room for maneuver that NTIs allow for adherence, Professor Pavel Klein demonstrates the double burden of this healthcare challenge and highlights the need for clinicians to support patients in their adherence efforts.

To learn more about the double-challenge of NTI adherence, watch Professor Pavel Klein’s video.


Speakers

PROF.
PAVEL KLEIN

United States of America

Share this post

Read more on this topic

Session: Panel discussion - Sharing reflections and best practice

Session: Congress introduction second day

Session: Panel discussion - Raising adherence as a public health priority

Session: Closing congress first day

Session: Patient perspectives of adherence and how these can help us improve o…

Session: International Society of Hypertension - Raising awareness on non-adhe…

Session: International Society of Gynecological Endocrinology - From treating …

Session: Closing congress

Session: Practical individual interventions any healthcare professionals can a…

Session: The challenge and causes of non-adherence

Session: The paradox of non-adherence to treatment in oncology

Session: Non-adherence is the new cardiovascular risk factor